|
| Press Releases |
|
 |
|
| Friday, August 15, 2025 |
|
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2025 (the 'Period'), reporting growth in both revenue and net profit despite an uncertain macroeconomic landscape. more info >> |
|
|
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球醫療器械製造公司業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2025年6月30日止六個月(「報告期」)的中期業績。儘管宏觀經濟環境未見明朗，集團的收入及純利仍雙雙錄得增長。 more info >> |
|
|
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司（"业聚医疗"或"集团"；股份代号：6929）今天宣布截至2025年6月30日止六个月("报告期")的中期业绩。尽管宏观经济环境未见明朗，集团的收入及纯利仍双双录得增长。 more info >> |
|
| Friday, March 7, 2025 |
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至截至2024年12月31日止年度（「年度」）的全年業績。 more info >> |
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（“业聚医疗”或“集团”；股份代号：6929）今天宣布截至截至2024年12月31日止年度（“年度”）的全年业绩。 more info >> |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
|
业聚医疗2024年上半年纯利达1,880万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929）今天宣布截至2024年6月30日止六个月(「报告期」)的中期业绩。 more info >> |
|
|
業聚醫療2024年上半年純利達1,880萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2024年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
| Wednesday, April 24, 2024 |
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验 |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Focus Graphite Develops and Validates AI-Enabled Graphite Flake Sizing Technology to Enhance Resource Valuation and Mine Planning
Jan 13, 2026 18:29 HKT/SGT
|
|
|
存儲龍頭兆易創新正式登陸港交所：商業化能力盡顯 業績增長動能強勁
Jan 13, 2026 15:25 HKT/SGT
|
|
|
存储龙头兆易创新正式登陆港交所：商业化能力尽显 业绩增长动能强劲
Jan 13, 2026 15:25 HKT/SGT
|
|
|
HKiNEDA Survey Reveals INEDs' Confidence in Hong Kong's Dual-Listing Surge and Digital Frontier
Jan 13, 2026 15:16 HKT/SGT
|
|
|
香港獨立非執行董事協會調查顯示 獨董對香港雙重上市浪潮與數字前沿充滿信心
Jan 13, 2026 15:16 HKT/SGT
|
|
|
盈立证券金钟办公室大围分行一月开幕 首季增至11间实体服务中心 双线布局 推动业务升级
Jan 13, 2026 15:06 HKT/SGT
|
|
|
Mitsubishi Motors Starts Production of Rogue Plug-in Hybrid and Navara OEM Models for Nissan
Jan 13, 2026 16:02 JST
|
|
|
uSMART Opens Admiralty Office and Tai Wai Branch in January
Jan 13, 2026 15:01 HKT/SGT
|
|
|
盈立證券金鐘辦公室大圍分行一月開幕
Jan 13, 2026 15:01 HKT/SGT
|
|
|
'Power Women' shaping Asia's tomorrow's cities honoured at ARES 2025 VIP celebration
Jan 13, 2026 14:14: JST
|
|
|
Australia Developers Triumph at the 20th PropertyGuru Asia Property Awards Grand Final
Jan 13, 2026 14:11: JST
|
|
|
TOYOTA、ハイエース（バン・ワゴン・コミューター）を一部改良
Jan 13, 2026 13:50: JST
|
|
|
Honda四輪事業のシンボルに新たな「Hマーク」を採用
Jan 13, 2026 13:50: JST
|
|
|
Additional Investment in Commercial Space Station Business and Acquisition of Experimental Module Usage Rights
Jan 13, 2026 14:34 JST
|
|
|
聯想之星與君聯資本所投小核酸藥物龍頭企業瑞博生物在港交所成功上市
Jan 13, 2026 13:04 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
